The CRISPR Battle Through the Lens of International Patent Harmonization

On Tuesday, May 7, the U.S. Court of Appeals for the Federal Circuit will hear argument in a long-awaited appeal addressing the inventorship of the Nobel Prize-winning CRISPR technology.

Related Keywords

Feng Zhang ,Shaanxi ,China ,Japan ,United States ,Japanese ,America ,Chinese ,Jennifer Doudna ,Davidj Kappos ,Emmanuelle Charpentier ,Japan Patent Office ,Opposition Division ,Us Court ,Trademark Office ,National Research Council ,Supreme Court Amgen ,European Patent Office ,Korean Intellectual Property Office ,Federal Circuit ,Nobel Prize ,Nobel Prize Winning ,Regularly Interspaced Short Palindromic Repeats ,Patent Trial ,Appeal Board ,Director Kappos ,Time Is Now ,America Invents Act ,National Intellectual Property Administration ,Global Dimensions ,Intellectual Property Rights ,Federal Circuit Address Harmonization ,Supreme Court ,